An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 211123
Company: SUN PHARM

Products on ANDA 211123

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MACITENTAN	MACITENTAN	10MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 211123

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/26/2025	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/211123Orig1s000TA_ltr.pdf

Therapeutic Equivalents for ANDA 211123

MACITENTAN

TABLET;ORAL; 10MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MACITENTAN	MACITENTAN	10MG	TABLET;ORAL	Prescription	No	AB	211128	ALEMBIC
MACITENTAN	MACITENTAN	10MG	TABLET;ORAL	Prescription	No	AB	211198	AUROBINDO PHARMA LTD
MACITENTAN	MACITENTAN	10MG	TABLET;ORAL	Prescription	No	AB	211120	LAURUS
MACITENTAN	MACITENTAN	10MG	TABLET;ORAL	Prescription	No	AB	211136	MSN
MACITENTAN	MACITENTAN	10MG	TABLET;ORAL	Prescription	No	AB	211123	SUN PHARM
OPSUMIT	MACITENTAN	10MG	TABLET;ORAL	Prescription	Yes	AB	204410	ACTELION

Top